Triggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes

In this paper, we test the hypothesis that triggering of a second T cell receptor (TCR) expressed on diabetogenic T cells might initiate the onset of diabetes. A cross between two TCR-transgenic strains, the BDC2.5 strain that carries diabetogenic TCRs and the A18 strain that carries receptors speci...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of experimental medicine 1999-08, Vol.190 (4), p.577-584
Hauptverfasser: Fossati, G, Cooke, A, Papafio, R Q, Haskins, K, Stockinger, B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 584
container_issue 4
container_start_page 577
container_title The Journal of experimental medicine
container_volume 190
creator Fossati, G
Cooke, A
Papafio, R Q
Haskins, K
Stockinger, B
description In this paper, we test the hypothesis that triggering of a second T cell receptor (TCR) expressed on diabetogenic T cells might initiate the onset of diabetes. A cross between two TCR-transgenic strains, the BDC2.5 strain that carries diabetogenic TCRs and the A18 strain that carries receptors specific for C5, was set up to monitor development of diabetes after activation through the C5 TCR. F1 BDC2. 5 x A18 mice developed diabetes spontaneously beyond 3-4 mo of age. Although their T cells express both TCRs constitutively, the A18 receptor is expressed at extremely low levels. In vitro activation of dual TCR T cells followed by adoptive transfer into neonatal or adult F1 mice resulted in diabetes onset and death within 10 d after transfer. In contrast, in vivo immunization of F1 mice with different forms of C5 antigen not only failed to induce diabetes but protected mice from the spontaneous onset of diabetes. We propose that antigenic stimulation of cells with low levels of TCR produces signals inadequate for full activation, resulting instead in anergy.
doi_str_mv 10.1084/jem.190.4.577
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2195608</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17319557</sourcerecordid><originalsourceid>FETCH-LOGICAL-c414t-ddb4a7934f6cf75bf72019afb1d7ef6c76f92e85d5efcc91b85260a8847b49883</originalsourceid><addsrcrecordid>eNqFkU1LAzEQhoMoWj-OXiUnb1uT3WSTXAQRv6DgpR4lZLOTNdImNdkK_ntTWkRPngZmHl7e4UHonJIpJZJdvcNyShWZsikXYg9NKGekUryR-2hCSF1XlBBxhI5zfieEMsbbQ3RECWOK13KCXufJDwMkHwZscAYbQ4_n2MJigRNYWI0x4Rhw700HYxwgeLu7Z2xNwKsEnxBG7EO_tqMvaHQ7GvIpOnBmkeFsN0_Qy_3d_Paxmj0_PN3ezCrLKBurvu-YEaphrrVO8M6JmlBlXEd7AWUnWqdqkLzn4KxVtJO8bomRkomOKSmbE3S9zV2tuyX0thRKZqFXyS9N-tLReP33EvybHuKnrqniLdkEXO4CUvxYQx710ufNkyZAXGfdKiVqwdi_IBVNieSigNUWtCnmnMD9tKFEb8zpYk4Xc5rpYq7wF79f-EVvVTXfSSOWig</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17319557</pqid></control><display><type>article</type><title>Triggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Fossati, G ; Cooke, A ; Papafio, R Q ; Haskins, K ; Stockinger, B</creator><creatorcontrib>Fossati, G ; Cooke, A ; Papafio, R Q ; Haskins, K ; Stockinger, B</creatorcontrib><description>In this paper, we test the hypothesis that triggering of a second T cell receptor (TCR) expressed on diabetogenic T cells might initiate the onset of diabetes. A cross between two TCR-transgenic strains, the BDC2.5 strain that carries diabetogenic TCRs and the A18 strain that carries receptors specific for C5, was set up to monitor development of diabetes after activation through the C5 TCR. F1 BDC2. 5 x A18 mice developed diabetes spontaneously beyond 3-4 mo of age. Although their T cells express both TCRs constitutively, the A18 receptor is expressed at extremely low levels. In vitro activation of dual TCR T cells followed by adoptive transfer into neonatal or adult F1 mice resulted in diabetes onset and death within 10 d after transfer. In contrast, in vivo immunization of F1 mice with different forms of C5 antigen not only failed to induce diabetes but protected mice from the spontaneous onset of diabetes. We propose that antigenic stimulation of cells with low levels of TCR produces signals inadequate for full activation, resulting instead in anergy.</description><identifier>ISSN: 0022-1007</identifier><identifier>EISSN: 1540-9538</identifier><identifier>DOI: 10.1084/jem.190.4.577</identifier><identifier>PMID: 10449528</identifier><language>eng</language><publisher>United States: The Rockefeller University Press</publisher><subject>Adoptive Transfer ; Animals ; Blood Glucose - analysis ; Clonal Anergy ; Complement C5 - genetics ; Complement C5 - immunology ; Diabetes Mellitus, Type 1 - immunology ; Diabetes Mellitus, Type 1 - prevention &amp; control ; H-2 Antigens ; Homeodomain Proteins - genetics ; Homeodomain Proteins - immunology ; Islets of Langerhans - immunology ; Mice ; Mice, Inbred NOD ; Mice, Transgenic ; Models, Immunological ; Original ; Receptors, Antigen, T-Cell ; Receptors, Antigen, T-Cell, alpha-beta ; Spleen - cytology ; Spleen - immunology ; T-Lymphocytes - immunology</subject><ispartof>The Journal of experimental medicine, 1999-08, Vol.190 (4), p.577-584</ispartof><rights>1999 The Rockefeller University Press 1999 The Rockefeller University Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c414t-ddb4a7934f6cf75bf72019afb1d7ef6c76f92e85d5efcc91b85260a8847b49883</citedby><cites>FETCH-LOGICAL-c414t-ddb4a7934f6cf75bf72019afb1d7ef6c76f92e85d5efcc91b85260a8847b49883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2195608/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2195608/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,886,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10449528$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fossati, G</creatorcontrib><creatorcontrib>Cooke, A</creatorcontrib><creatorcontrib>Papafio, R Q</creatorcontrib><creatorcontrib>Haskins, K</creatorcontrib><creatorcontrib>Stockinger, B</creatorcontrib><title>Triggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes</title><title>The Journal of experimental medicine</title><addtitle>J Exp Med</addtitle><description>In this paper, we test the hypothesis that triggering of a second T cell receptor (TCR) expressed on diabetogenic T cells might initiate the onset of diabetes. A cross between two TCR-transgenic strains, the BDC2.5 strain that carries diabetogenic TCRs and the A18 strain that carries receptors specific for C5, was set up to monitor development of diabetes after activation through the C5 TCR. F1 BDC2. 5 x A18 mice developed diabetes spontaneously beyond 3-4 mo of age. Although their T cells express both TCRs constitutively, the A18 receptor is expressed at extremely low levels. In vitro activation of dual TCR T cells followed by adoptive transfer into neonatal or adult F1 mice resulted in diabetes onset and death within 10 d after transfer. In contrast, in vivo immunization of F1 mice with different forms of C5 antigen not only failed to induce diabetes but protected mice from the spontaneous onset of diabetes. We propose that antigenic stimulation of cells with low levels of TCR produces signals inadequate for full activation, resulting instead in anergy.</description><subject>Adoptive Transfer</subject><subject>Animals</subject><subject>Blood Glucose - analysis</subject><subject>Clonal Anergy</subject><subject>Complement C5 - genetics</subject><subject>Complement C5 - immunology</subject><subject>Diabetes Mellitus, Type 1 - immunology</subject><subject>Diabetes Mellitus, Type 1 - prevention &amp; control</subject><subject>H-2 Antigens</subject><subject>Homeodomain Proteins - genetics</subject><subject>Homeodomain Proteins - immunology</subject><subject>Islets of Langerhans - immunology</subject><subject>Mice</subject><subject>Mice, Inbred NOD</subject><subject>Mice, Transgenic</subject><subject>Models, Immunological</subject><subject>Original</subject><subject>Receptors, Antigen, T-Cell</subject><subject>Receptors, Antigen, T-Cell, alpha-beta</subject><subject>Spleen - cytology</subject><subject>Spleen - immunology</subject><subject>T-Lymphocytes - immunology</subject><issn>0022-1007</issn><issn>1540-9538</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1LAzEQhoMoWj-OXiUnb1uT3WSTXAQRv6DgpR4lZLOTNdImNdkK_ntTWkRPngZmHl7e4UHonJIpJZJdvcNyShWZsikXYg9NKGekUryR-2hCSF1XlBBxhI5zfieEMsbbQ3RECWOK13KCXufJDwMkHwZscAYbQ4_n2MJigRNYWI0x4Rhw700HYxwgeLu7Z2xNwKsEnxBG7EO_tqMvaHQ7GvIpOnBmkeFsN0_Qy_3d_Paxmj0_PN3ezCrLKBurvu-YEaphrrVO8M6JmlBlXEd7AWUnWqdqkLzn4KxVtJO8bomRkomOKSmbE3S9zV2tuyX0thRKZqFXyS9N-tLReP33EvybHuKnrqniLdkEXO4CUvxYQx710ufNkyZAXGfdKiVqwdi_IBVNieSigNUWtCnmnMD9tKFEb8zpYk4Xc5rpYq7wF79f-EVvVTXfSSOWig</recordid><startdate>19990816</startdate><enddate>19990816</enddate><creator>Fossati, G</creator><creator>Cooke, A</creator><creator>Papafio, R Q</creator><creator>Haskins, K</creator><creator>Stockinger, B</creator><general>The Rockefeller University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19990816</creationdate><title>Triggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes</title><author>Fossati, G ; Cooke, A ; Papafio, R Q ; Haskins, K ; Stockinger, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c414t-ddb4a7934f6cf75bf72019afb1d7ef6c76f92e85d5efcc91b85260a8847b49883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adoptive Transfer</topic><topic>Animals</topic><topic>Blood Glucose - analysis</topic><topic>Clonal Anergy</topic><topic>Complement C5 - genetics</topic><topic>Complement C5 - immunology</topic><topic>Diabetes Mellitus, Type 1 - immunology</topic><topic>Diabetes Mellitus, Type 1 - prevention &amp; control</topic><topic>H-2 Antigens</topic><topic>Homeodomain Proteins - genetics</topic><topic>Homeodomain Proteins - immunology</topic><topic>Islets of Langerhans - immunology</topic><topic>Mice</topic><topic>Mice, Inbred NOD</topic><topic>Mice, Transgenic</topic><topic>Models, Immunological</topic><topic>Original</topic><topic>Receptors, Antigen, T-Cell</topic><topic>Receptors, Antigen, T-Cell, alpha-beta</topic><topic>Spleen - cytology</topic><topic>Spleen - immunology</topic><topic>T-Lymphocytes - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fossati, G</creatorcontrib><creatorcontrib>Cooke, A</creatorcontrib><creatorcontrib>Papafio, R Q</creatorcontrib><creatorcontrib>Haskins, K</creatorcontrib><creatorcontrib>Stockinger, B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of experimental medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fossati, G</au><au>Cooke, A</au><au>Papafio, R Q</au><au>Haskins, K</au><au>Stockinger, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Triggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes</atitle><jtitle>The Journal of experimental medicine</jtitle><addtitle>J Exp Med</addtitle><date>1999-08-16</date><risdate>1999</risdate><volume>190</volume><issue>4</issue><spage>577</spage><epage>584</epage><pages>577-584</pages><issn>0022-1007</issn><eissn>1540-9538</eissn><abstract>In this paper, we test the hypothesis that triggering of a second T cell receptor (TCR) expressed on diabetogenic T cells might initiate the onset of diabetes. A cross between two TCR-transgenic strains, the BDC2.5 strain that carries diabetogenic TCRs and the A18 strain that carries receptors specific for C5, was set up to monitor development of diabetes after activation through the C5 TCR. F1 BDC2. 5 x A18 mice developed diabetes spontaneously beyond 3-4 mo of age. Although their T cells express both TCRs constitutively, the A18 receptor is expressed at extremely low levels. In vitro activation of dual TCR T cells followed by adoptive transfer into neonatal or adult F1 mice resulted in diabetes onset and death within 10 d after transfer. In contrast, in vivo immunization of F1 mice with different forms of C5 antigen not only failed to induce diabetes but protected mice from the spontaneous onset of diabetes. We propose that antigenic stimulation of cells with low levels of TCR produces signals inadequate for full activation, resulting instead in anergy.</abstract><cop>United States</cop><pub>The Rockefeller University Press</pub><pmid>10449528</pmid><doi>10.1084/jem.190.4.577</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1007
ispartof The Journal of experimental medicine, 1999-08, Vol.190 (4), p.577-584
issn 0022-1007
1540-9538
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2195608
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Adoptive Transfer
Animals
Blood Glucose - analysis
Clonal Anergy
Complement C5 - genetics
Complement C5 - immunology
Diabetes Mellitus, Type 1 - immunology
Diabetes Mellitus, Type 1 - prevention & control
H-2 Antigens
Homeodomain Proteins - genetics
Homeodomain Proteins - immunology
Islets of Langerhans - immunology
Mice
Mice, Inbred NOD
Mice, Transgenic
Models, Immunological
Original
Receptors, Antigen, T-Cell
Receptors, Antigen, T-Cell, alpha-beta
Spleen - cytology
Spleen - immunology
T-Lymphocytes - immunology
title Triggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T23%3A32%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Triggering%20a%20second%20T%20cell%20receptor%20on%20diabetogenic%20T%20cells%20can%20prevent%20induction%20of%20diabetes&rft.jtitle=The%20Journal%20of%20experimental%20medicine&rft.au=Fossati,%20G&rft.date=1999-08-16&rft.volume=190&rft.issue=4&rft.spage=577&rft.epage=584&rft.pages=577-584&rft.issn=0022-1007&rft.eissn=1540-9538&rft_id=info:doi/10.1084/jem.190.4.577&rft_dat=%3Cproquest_pubme%3E17319557%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17319557&rft_id=info:pmid/10449528&rfr_iscdi=true